MLKN$20.84
$21.22
Chart
Performance
Key Stats
AI MLKN Summary
Powered by LiveAIAI Scoreboard
Powered by LiveAIOverall Analysis
NeutralMillerKnoll shows a mixed profile with some fundamental strengths but faces challenges in profitability and a deteriorating technical outlook. Thematic positioning is average.
Thematic
MillerKnoll operates in the interior furnishings sector, which has moderate exposure to broad economic trends but lacks strong, specific growth themes.
Fundamental
MillerKnoll exhibits a stable balance sheet and some positive revenue trends, but profitability has been inconsistent and is currently weak.
Technical
The stock is trading below key moving averages and shows weak momentum across multiple timeframes, suggesting a bearish short-term trend.
| Factor | Score |
|---|---|
| Hybrid Work Trends | 70 |
| E-commerce Penetration | 65 |
| Sustainability Focus | 50 |
| Residential vs. Commercial | 55 |
| Brand Diversification | 60 |
| Factor | Score |
|---|---|
| Valuation | 50 |
| Profitability | 45 |
| Growth | 40 |
| Balance Sheet Health | 60 |
| Cash Flow | 80 |
| Factor | Score |
|---|---|
| Trend Analysis | 30 |
| Momentum | 60 |
| Volume Confirmation | 50 |
| Support & Resistance | 80 |
AI Investing Checklist
Powered by LiveAIBullish Points (6)
Positive EPS Surprise
The latest reported EPS of $0.60 exceeded the estimate of $0.44 by 37.3%, indicating stronger-than-expected profitability.
Favorable Trailing P/E Ratio
The trailing Price-to-Earnings (P/E) ratio is 66.1, which, while appearing high, is considered reasonable in the context of its sector and potential for future growth.
Bearish Points (8)
Negative EPS in Some Quarters
The company reported negative EPS ($-0.54) on a trailing twelve months (TTM) basis, indicating recent unprofitability.
High Price-to-Sales Ratio
The trailing Price-to-Sales (P/S) ratio is 0.5, which is consistent with historical data, but the TTM P/E ratio of 66.1 suggests a high valuation relative to current earnings.
Calendar
May 2025
30
Ex-Dividend Date
July 2025
15
Next Dividend Date
September 2025
18
Next Earnings Date
H: $0.36
A: $0.34
L: $0.33
H: 920.90M
A: 910.97M
L: 905.60M
Profile
MillerKnoll, Inc. researches, designs, manufactures, and distributes interior furnishings worldwide. It operates through three segments: Americas Contract, International Contract & Specialty, and Global Retail. The company also provides seating products, furniture systems, other freestanding furniture elements, textiles, leather, felt, home furnishings and related services, casegoods, storage products, as well as residential, education, and healthcare furniture solutions. It offers its products under the MillerKnoll, Herman Miller, Herman Miller Circled Symbolic M, Knoll, Maharam, Geiger, Design Within Reach, DWR, HAY, NaughtOne, Nemschoff, Aeron, Mirra, Embody, Setu, Sayl, Cosm, Caper, Eames, Knoll, KnollExtra, Knoll Luxe, KnollStudio, KnollTextiles, Edelman Leather, Spinneybeck Leather, Generation by Knoll, Regeneration by Knoll, MultiGeneration by Knoll, Remix, Holly Hunt, Vladimir Kagan, Muuto, Barcelona, and Womb names. The company offers its products through independent contract furniture dealers, direct contract sales, e-commerce websites, and wholesale and retail stores. Its products are used in institutional, health/science, and residential and other environments, and industrial and educational settings, as well as transportation terminals. The company also operates an archival collection space for brands and researchers. The company was formerly known as Herman Miller, Inc. and changed its name to MillerKnoll, Inc. in November 2021. MillerKnoll, Inc. was incorporated in 1905 and is headquartered in Zeeland, Michigan.
Seasonals
Price Target
38.00 USD
The 39 analysts offering 1 year price forecasts for MLKN have a max estimate of 38.00 and a min estimate of 38.00.
Debt Level and Coverage
Financial Position Analysis
Ownership
Capital Structure
Valuation - Summary
Valuation - Ratios
Revenue to Profit Conversion
Balance Sheet
Income Statement
Cash Flow
Related Companies
Powered by LiveAIWeight: 98
A major generic pharmaceutical company with significant exposure to opioid litigation, paralleling Mallinckrodt's historical business model and legal challenges.
Weight: 95
Formed from the merger of Mylan (a generic peer) and Pfizer's Upjohn unit, Viatris is a global pharmaceutical company with a large portfolio of established brands and generics, reflecting a similar strategic approach to mature products.
Weight: 92
A specialty pharmaceutical company that focuses on acquiring and commercializing approved products, particularly in areas like pain management, mirroring a key part of Mallinckrodt's strategy.
Weight: 90
Specializes in developing and commercializing therapies for rare diseases and high-need areas, aligning with Mallinckrodt's focus on specialty and orphan drugs like Acthar Gel.